{
  "actions": [
    {
      "acted_at": "2007-03-13", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2007-03-13", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "text": "Referred to House Energy and Commerce", 
      "type": "referral"
    }, 
    {
      "acted_at": "2007-03-13", 
      "committees": [
        "HSJU"
      ], 
      "references": [], 
      "text": "Referred to House Judiciary", 
      "type": "referral"
    }, 
    {
      "acted_at": "2007-03-13", 
      "committees": [
        "HSWM"
      ], 
      "references": [], 
      "text": "Referred to House Ways and Means", 
      "type": "referral"
    }, 
    {
      "acted_at": "2007-03-14", 
      "in_committee": null, 
      "references": [], 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2007-04-20", 
      "in_committee": null, 
      "references": [], 
      "text": "Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr1496-110", 
  "bill_type": "hr", 
  "by_request": false, 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }, 
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Judiciary", 
      "committee_id": "HSJU"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Judiciary", 
      "committee_id": "HSJU", 
      "subcommittee": "Subcommittee on Courts, the Internet, and Intellectual Property", 
      "subcommittee_id": "03"
    }, 
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Ways and Means", 
      "committee_id": "HSWM"
    }
  ], 
  "congress": "110", 
  "cosponsors": [
    {
      "district": "31", 
      "name": "Carter, John R.", 
      "sponsored_at": "2007-06-11", 
      "state": "TX", 
      "thomas_id": "01752", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Cubin, Barbara", 
      "sponsored_at": "2007-03-13", 
      "state": "WY", 
      "thomas_id": "00254", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "7", 
      "name": "Ferguson, Mike", 
      "sponsored_at": "2007-09-06", 
      "state": "NJ", 
      "thomas_id": "01659", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "2", 
      "name": "Matheson, Jim", 
      "sponsored_at": "2007-03-13", 
      "state": "UT", 
      "thomas_id": "01671", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2007-03-13", 
  "number": "1496", 
  "official_title": "To provide incentives for pharmaceutical companies, biotechnology companies, and medical device companies to invest in research and development with respect to antibiotic drugs, antivirals, diagnostic tests, and vaccines that may be used to identify, treat, or prevent serious and life-threatening infectious diseases.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Beating Infections through Research and Development Act of 2007", 
  "sponsor": {
    "district": "3", 
    "name": "Baird, Brian", 
    "state": "WA", 
    "thomas_id": "01557", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2007-03-13", 
  "subjects": [
    "Administrative procedure", 
    "Antibiotics", 
    "Biotechnology", 
    "Clinical trials", 
    "Commerce", 
    "Communicable diseases", 
    "Congressional reporting requirements", 
    "Department of Health and Human Services", 
    "Drug approvals", 
    "Drug industry", 
    "Drug resistance in microorganisms", 
    "Executive reorganization", 
    "Federal advisory bodies", 
    "Food and Drug Administration (FDA)", 
    "Government operations and politics", 
    "Government paperwork", 
    "Health", 
    "Income tax", 
    "Influenza", 
    "Intellectual property", 
    "Investment tax credit", 
    "Law", 
    "Medical tests", 
    "Patents", 
    "Pharmaceutical research", 
    "Public health", 
    "Research and development", 
    "Research and development tax credit", 
    "Science, technology, communications", 
    "Small business", 
    "State laws", 
    "Surveys", 
    "Tax administration", 
    "Taxation", 
    "Vaccines"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2007-03-13", 
    "text": "Beating Infections through Research and Development Act of 2007 - Sets forth circumstances under which the term of a patent may be extended for qualified infectious disease products.\n\nRequires the Secretary of Health and Human Services to designate qualified infectious disease products as fast-track products for approval.\n\nAmends the Public Health Service Act to require the Director of the National Institute of Allergy and Infectious Diseases to expand and intensify efforts to assist small manufacturers to conduct end-stage clinical trials on qualified infectious disease products.\n\nAmends the Internal Revenue Code to establish an infectious disease research credit and a qualified infectious disease products manufacturing facilities investment credit.\n\nEstablishes the Commission on Infectious Diseases Product Development to identify drug-resistant infectious pathogens that are a significant threat to public health and make recommendations to the Secretary on how best to address such pathogens.\n\nAmends the Federal Food, Drug, and Cosmetic Act to require the Secretary, acting through the Commissioner of Food and Drugs, to issue guidelines for the conduct of clinical trials with respect to antibiotic drugs."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Beating Infections through Research and Development Act of 2007", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To provide incentives for pharmaceutical companies, biotechnology companies, and medical device companies to invest in research and development with respect to antibiotic drugs, antivirals, diagnostic tests, and vaccines that may be used to identify, treat, or prevent serious and life-threatening infectious diseases.", 
      "type": "official"
    }
  ], 
  "updated_at": "2016-06-29T09:29:51-04:00", 
  "url": "http://thomas.loc.gov/cgi-bin/bdquery/z?d110:HR1496:@@@L&summ2=m&"
}